C Ramesh
Research Subjects
C Ramesh has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alisha M. Jain2 shared publications
- Amith Kumar B
Department of Pharmacognosy, Bapuji Pharmacy College, Davangere, India
2 shared publications - B. A. Sowmya
Department of Pharmacology, East West College of Pharmacy, Bengaluru, India, 560091
2 shared publications - Krishna Pundi
Department of Pharmaceutical Chemistry, East West College of Pharmacy, Bangalore, India
2 shared publications A Madhu
Department of Pharmacology, East West College of Pharmacy, Bangalore-560091, India
1 shared publication- Nayaka Raghavendra Babu
Department of Pharmaceutical Chemistry, G. Pulla Reddy College of Pharmacy, Mehdipatnam, Hyderabad, 500028, India
1 shared publication
Latest Publications
- Open Access
- 21 April 2026
- Published by Pharma Research Library in World Journal of Pharmacy and Biotechnology
- Vol. 13 (02) , 59-64
Hansen Solubility Parameters in Pharmaceutical Cocrystal Screening: From Group Contribution Methods to Machine Learning-Assisted Prediction
This review summarizes the theoretical basis of HSPs and discusses the major group contribution methods used for HSP estimation, including the Fedors, Hoy, and Van Krevelen approaches. The application of HSPs in pharmaceutical cocrystal screening, acceptance criteria for cocrystal prediction, and representative case studies involving poorly soluble drugs are critically examined. The advantages and limitations of HSP-based prediction methods are also discussed, highlighting the need for experimental validation of predicted cocrystal systems. Furthermore, recent advances involving machine learning, artificial intelligence, molecular descriptors, and COSMO-RS-assisted screening strategies are reviewed as emerging approaches to improve prediction accuracy and coformer selection. The integration of traditional group contribution methods with modern computational technologies is expected to accelerate pharmaceutical cocrystal discovery and reduce experimental workload. Overall, HSP-based screening remains a valuable and practical tool for early-stage cocrystal development and continues to evolve through advances in data-driven and computational methodologies.
- 21 April 2026
- Published by Pharma Research Library in World Journal of Pharmacy and Biotechnology
- Vol. 13 (02) , 59-64
Open AccessHansen Solubility Parameters in Pharmaceutical Cocrystal Screening: From Group Contribution Methods to Machine Learning-Assisted Prediction
This review summarizes the theoretical basis of HSPs and discusses the major group contribution methods used for HSP estimation, including the Fedors, Hoy, and Van Krevelen approaches. The application of HSPs in pharmaceutical cocrystal screening, acceptance criteria for cocrystal prediction, and representative case studies involving poorly soluble drugs are critically examined. The advantages and limitations of HSP-based prediction methods are also discussed, highlighting the need for experimental validation of predicted cocrystal systems. Furthermore, recent advances involving machine learning, artificial intelligence, molecular descriptors, and COSMO-RS-assisted screening strategies are reviewed as emerging approaches to improve prediction accuracy and coformer selection. The integration of traditional group contribution methods with modern computational technologies is expected to accelerate pharmaceutical cocrystal discovery and reduce experimental workload. Overall, HSP-based screening remains a valuable and practical tool for early-stage cocrystal development and continues to evolve through advances in data-driven and computational methodologies.
- Open Access
- 13 April 2026
- Published by Pharma Research Library in Asian Journal of Medical and Pharmaceutical Sciences
- Vol. 14 (02) , 57-62
From Biodiversity to Drug Discovery: Pharmacological Significance and Conservation of Endangered Medicinal Plants
Background: Medicinal plants have served as a cornerstone for drug discovery and traditional healthcare systems for centuries. However, a significant proportion of these biologically valuable species are currently threatened due to anthropogenic pressures and ecological changes. Objective: This review aims to critically evaluate pharmacologically important endangered medicinal plants, focusing on their phytochemical composition, therapeutic potential, and conservation challenges. Methods: A comprehensive literature survey was conducted using databases such as PubMed, Scopus, and Web of Science, covering publications from 2021 to 2026. Studies were selected based on relevance to endangered status, pharmacological validation, and phytochemical characterization. Results: Several endangered plants, including Rauvolfia serpentina, Coscinium fenestratum, Angelica glauca, Chlorophytum borivilianum, and Saussurea costus, exhibit significant pharmacological activities such as antihypertensive, antimicrobial, anti-inflammatory, immunomodulatory, and anticancer effects. These activities are attributed to diverse phytoconstituents including alkaloids, flavonoids, terpenoids, and glycosides. Conclusion: Endangered medicinal plants represent a valuable yet diminishing resource for drug discovery. Integrating pharmacological research with conservation strategies is essential to ensure sustainable utilization and preservation of these species.
- 13 April 2026
- Published by Pharma Research Library in Asian Journal of Medical and Pharmaceutical Sciences
- Vol. 14 (02) , 57-62
Open AccessFrom Biodiversity to Drug Discovery: Pharmacological Significance and Conservation of Endangered Medicinal Plants
Background: Medicinal plants have served as a cornerstone for drug discovery and traditional healthcare systems for centuries. However, a significant proportion of these biologically valuable species are currently threatened due to anthropogenic pressures and ecological changes. Objective: This review aims to critically evaluate pharmacologically important endangered medicinal plants, focusing on their phytochemical composition, therapeutic potential, and conservation challenges. Methods: A comprehensive literature survey was conducted using databases such as PubMed, Scopus, and Web of Science, covering publications from 2021 to 2026. Studies were selected based on relevance to endangered status, pharmacological validation, and phytochemical characterization. Results: Several endangered plants, including Rauvolfia serpentina, Coscinium fenestratum, Angelica glauca, Chlorophytum borivilianum, and Saussurea costus, exhibit significant pharmacological activities such as antihypertensive, antimicrobial, anti-inflammatory, immunomodulatory, and anticancer effects. These activities are attributed to diverse phytoconstituents including alkaloids, flavonoids, terpenoids, and glycosides. Conclusion: Endangered medicinal plants represent a valuable yet diminishing resource for drug discovery. Integrating pharmacological research with conservation strategies is essential to ensure sustainable utilization and preservation of these species.
- Open Access
- 15 November 2023
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 13 (11) , 26-30
The ethanol extract of Muntingia calabura exhibits in vitro antidiabetic potentials by inhibiting carbohydrate digestive enzymes
Objective: The present research study was conducted to investigate in vitro anti-diabetic potentials of ethanol extract of leaves of Muntingia calabura for α-glucosidase and α-amylase inhibitory activities. Materials & Methods: The leaves of Muntingia calabura were collected and authenticated. dried and powdered. The powdered drug was defatted using petroleum ether and extracted with ethanol. The ethanol extract of Muntingia calabura was subjected to preliminary phytochemical investigation. The in vitro α-glucosidase inhibitory and α-amylase inhibitory properties were determined for the ethanol extract and concentrations of extract required to inhibit absorbance (IC50 values) EEMC were determined. Results: Significant IC50 values were found in both tests that assessed the inhibitory activity of α-glucosidase and α-amylase, demonstrating the capacity of the ethanol extract of Muntingia calabura to block carbohydrate digesting enzymes and prevent postprandial blood glucose. Conclusion: The results of the presents investigation recommends that ethanol extract of Muntingia calabura possess significant α-glucosidase and α-amylase inhibitory activity. Keywords: Antidiabetic activity, Muntingia calabura, α-glucosidase and α-amylase and IC50values.
- 15 November 2023
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 13 (11) , 26-30
Open AccessThe ethanol extract of Muntingia calabura exhibits in vitro antidiabetic potentials by inhibiting carbohydrate digestive enzymes
Objective: The present research study was conducted to investigate in vitro anti-diabetic potentials of ethanol extract of leaves of Muntingia calabura for α-glucosidase and α-amylase inhibitory activities. Materials & Methods: The leaves of Muntingia calabura were collected and authenticated. dried and powdered. The powdered drug was defatted using petroleum ether and extracted with ethanol. The ethanol extract of Muntingia calabura was subjected to preliminary phytochemical investigation. The in vitro α-glucosidase inhibitory and α-amylase inhibitory properties were determined for the ethanol extract and concentrations of extract required to inhibit absorbance (IC50 values) EEMC were determined. Results: Significant IC50 values were found in both tests that assessed the inhibitory activity of α-glucosidase and α-amylase, demonstrating the capacity of the ethanol extract of Muntingia calabura to block carbohydrate digesting enzymes and prevent postprandial blood glucose. Conclusion: The results of the presents investigation recommends that ethanol extract of Muntingia calabura possess significant α-glucosidase and α-amylase inhibitory activity. Keywords: Antidiabetic activity, Muntingia calabura, α-glucosidase and α-amylase and IC50values.
- Open Access
- 15 November 2023
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 13 (11) , 21-25
The ethanol extract of Syzygium cumini exhibits cytotoxic potentials against breast cancer cells due to antioxidant properties
The present investigation was designed to evaluate in vitro cytotoxic potentials of ethanol extract of Syzygium cumini against breast cancer cells and also estimate its antioxidant activity. The ethanol extract of Syzygium cumini was prepared by successive solvent extraction process using sox-let apparatus. The ethanol extract was evaluated for its in-vitro anticancer potentials against MCF-7 human breast cancer cell lines by MTT assay and concentration of the ethanol extract required to inhibit 50% of cell growth (IC50) was recorded. To determine antioxidant properties of the extract, superoxide scavenging, lipid peroxidation and DPPH methods were used and IC50 values of extracts were noted. In current study, ethanol extract of Syzygium cumini has shown anticancer property by exhibiting significant IC50 values against growth of breast cancer cell growth. The extract has also shown significant IC50 values in superoxide scavenging, lipid peroxidation and DPPH methods and antioxidant activity was comparable to standard drug ascorbic acid. The results obtained from the present research work suggested that the ethanol extract of Syzygium cumini possess significant in vitro cytotoxic potentials against breast cancer cells. The results also suggested that the ethanol extract have in vitro antioxidant properties. Keywords: Anticancer activity, Syzygium cumini, IC50 value, MTT assay and antioxidant activity.
- 15 November 2023
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 13 (11) , 21-25
Open AccessThe ethanol extract of Syzygium cumini exhibits cytotoxic potentials against breast cancer cells due to antioxidant properties
The present investigation was designed to evaluate in vitro cytotoxic potentials of ethanol extract of Syzygium cumini against breast cancer cells and also estimate its antioxidant activity. The ethanol extract of Syzygium cumini was prepared by successive solvent extraction process using sox-let apparatus. The ethanol extract was evaluated for its in-vitro anticancer potentials against MCF-7 human breast cancer cell lines by MTT assay and concentration of the ethanol extract required to inhibit 50% of cell growth (IC50) was recorded. To determine antioxidant properties of the extract, superoxide scavenging, lipid peroxidation and DPPH methods were used and IC50 values of extracts were noted. In current study, ethanol extract of Syzygium cumini has shown anticancer property by exhibiting significant IC50 values against growth of breast cancer cell growth. The extract has also shown significant IC50 values in superoxide scavenging, lipid peroxidation and DPPH methods and antioxidant activity was comparable to standard drug ascorbic acid. The results obtained from the present research work suggested that the ethanol extract of Syzygium cumini possess significant in vitro cytotoxic potentials against breast cancer cells. The results also suggested that the ethanol extract have in vitro antioxidant properties. Keywords: Anticancer activity, Syzygium cumini, IC50 value, MTT assay and antioxidant activity.